NRG-GU013: THE PHASE III HIGH FIVE TRIAL FIVE FRACTION RADIATION FOR HIGH-RISK PROSTATE CANCER

Sponsor:

NRG

Sponsor Study ID:

NRG-GU013

CTO #:

104197

NCT Number:

NCT05946213

Phase:

III

Protocol Type:

Treatment

Age Group:

Adults

Disease Sites:

Prostate

Study Objectives:

To compare metastasis-free survival, determined using conventional imaging, between men with high-risk prostate cancer randomized to ultrahypofractionation (SBRT) to those randomized to moderate hypofractionation and conventional fractionation

eConsent:

Not available

Study Documents:

Open Study Documents
(MUSC NetID required for document access)